Literature DB >> 22539053

Predictive index for lymph node management of major salivary gland cancer.

Yu-Long Wang1, Duan-Shu Li, Hua-Lei Gan, Zhong-Wu Lu, Hui Li, Guo-Pei Zhu, Cai-Ping Huang, Yong-Xue Zhu, Tong-Zhen Chen, Yu Wang, Guo-Hua Sun, Zhuo-Ying Wang, Qiang Shen, Yi Wu, Qing-Hai Ji.   

Abstract

OBJECTIVES/HYPOTHESIS: To find the risk factors of lymph node (LN) metastasis of salivary gland cancer and draw a scheme for LN management. STUDY
DESIGN: Hospital-based retrospective study.
METHODS: The records of salivary gland cancer patients treated at the Department of Head and Neck Surgery, Cancer Hospital, Fudan University, were entered in a database, and 219 consecutive patients with carcinomas of major salivary glands primarily operated on between January 1998 and January 2011 were chosen for univariate and multivariate analysis to identify risk factors for LN involvement.
RESULTS: Fifty-eight (26.5%) patients had LN involvement. Factors associated with cervical LN involvement on univariate analysis included pathologic type, male sex, shorter duration of preoperative course, facial paralysis, advanced T stage, and major nerve, soft tissue, lymphatic/vascular (L/V), neural/perineural, and extracapsular invasion. Multivariate analysis identified major nerve invasion, histologic type, L/V invasion, and extracapsular invasion as significant factors for LN involvement. The proportion of patients with LN involvement with low (105), middle (61), high (34), and super high (19) predictive index scores based on the four risk factors were 3.8%, 27.9%, 55.9%, and 94.7%, respectively.
CONCLUSIONS: A predictive index using the clinicopathologic factors described in this report can effectively stratify patients into risk groups for nodal metastasis. Comprehensive management based on this risk index should improve treatment outcomes for patients with salivary gland cancer.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22539053     DOI: 10.1002/lary.23227

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Elective neck dissection in adenoid cystic carcinoma of head and neck: yes or no? A systematic review.

Authors:  Ivica Luksic; Petar Suton
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-03       Impact factor: 2.503

2.  Salivary gland tumors: A 20-year review of clinical diagnostic accuracy at a single center.

Authors:  Wei-Han Lee; Te-Ming Tseng; Hsin-Te Hsu; Fei-Peng Lee; Shih-Han Hung; Po-Yueh Chen
Journal:  Oncol Lett       Date:  2013-12-10       Impact factor: 2.967

3.  IMRT with Stereotactic Body Radiotherapy Boost for High Risk Malignant Salivary Gland Malignancies: A Case Series.

Authors:  Sana D Karam; Abdul Rashid; James W Snider; Margaux Wooster; Shilpa Bhatia; Ann K Jay; Kenneth Newkirk; Bruce Davidson; William K Harter
Journal:  Front Oncol       Date:  2014-10-21       Impact factor: 6.244

4.  Develop and validation a nomogram to predict the recurrent probability in patients with major salivary gland cancer.

Authors:  Chang-Hsien Lu; Chien-Ting Liu; Pei-Hung Chang; Chia-Yen Hung; Shau-Hsuan Li; Ta-Sen Yeh; Yung-Shin Hung; Wen-Chi Chou
Journal:  J Cancer       Date:  2017-07-20       Impact factor: 4.207

5.  Lymph node ratio (LNR) as a complementary staging system to TNM staging in salivary gland cancer.

Authors:  Bo-Wen Lei; Jia-Qian Hu; Peng-Cheng Yu; Yu-Long Wang; Wen-Jun Wei; Ji Zhu; Xiao Shi; Ning Qu; Zhong-Wu Lu; Qing-Hai Ji
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-11       Impact factor: 2.503

6.  Management of clinically negative neck in salivary gland cancers - elective neck dissection, irradiation, or surveillance?

Authors:  Mateusz Szewczyk; Paweł Golusiński; Jakub Pazdrowski; Piotr Pieńkowski; Wojciech J Golusiński
Journal:  Contemp Oncol (Pozn)       Date:  2019-10-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.